8-K filing — ROCKWELL MEDICAL, INC. (RMTI)
Filed: 2026-08-13 AccNo: 0001628280-26-056470 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Rockwell Medical Stock Keeps Nasdaq Listing After Compliance Notice
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Rockwell Medical Q2 Adj. EPS $(0.04) Beats $(0.23) Estimate, Sales $17.780M Miss $17.837M Estimate
Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.23) by 82.61 percent. This is a 300 percent decrease over losses of $(0.01) per share from
Rockwell Medical Affirms FY2026 Sales Guidance of $70.000M-$75.000M vs $72.469M Est
Rockwell Medical (NASDAQ:RMTI) affirms FY2026 sales outlook from $70.000 million-$75.000 million to $70.000 million-$75.000 million vs $72.469 million estimate.